Public Health Agency of Canada
Symbol of the Government of Canada

Share this page

National Advisory Committee on Immunization (NACI)

About NACI

NACI is a national advisory committee of experts in the fields of pediatrics, infectious diseases, immunology, medical microbiology, internal medicine and public health. The Committee reports to the Assistant Deputy Minister of Infectious Disease Prevention and Control, and works with staff of the Centre for Immunization and Respiratory Infectious Diseases of the Public Health Agency of Canada to provide ongoing and timely medical, scientific and public health advice.

NACI makes recommendations for the use of vaccines currently or newly approved for use in humans in Canada, including the identification of groups at risk for vaccine-preventable diseases for whom vaccination should be targeted. NACI knowledge syntheses, analyses and recommendations on vaccine use in Canada are included in published literature reviews, statements and updates. NACI recommendations are also published in the Canadian Immunization Guide.

NACI Recommendations, Statements and Updates
Subject* Title Date
Bacille Calmette Guérin (BCG) Statement on Bacille Calmette Guérin (BCG) Vaccine 

Erratum 2005
2004
Cholear Implant Recipients Immunization Recommendations for Cochlear Implant RecipientsExternal link 2003
Haemophilus Influenzae Type B Statement on the recommended use of pentavalent and hexavalent vaccines 2007
Haemophilus Influenzae Type B Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B  Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age 2005
Hepatitis Statement on the recommended use of pentavalent and hexavalent vaccines 2007
Hepatitis Update on hepatitis A vaccine (AVAXIM®, Aventis Pasteur)External link
2001
Hepatitis Statement on Alternate Adolescent Schedule for Hepatitis B VaccineExternal link
2000
Hepatitis Supplementary Statement on Hepatitis A VaccineExternal link
2000
Hepatitis Supplementary statement on hepatitis prevention - hepatitis A and hepatitis B combination vaccine for childrenExternal link
1999
Hepatitis Statement on combination vaccines against hepatitis A and hepatitis BExternal link
1999
Human Papillomavirus Update on Human Papillomavirus (HPV) Vaccines
2012
Human Papillomavirus Statement on Human Papillomavirus Vaccine
2007
Human Papillomavirus Literature review on HPV 6, 11, 16 and 18: Disease and Vaccine Characteristics 2007
Immunization Schedule Immunization Schedules for Children and Adults
2013
Immunization Evidence-based recommendations for immunization – Methods of the National Advisory Committee on Immunization
2009
Influenza Statement on Seasonal Influenza Vaccine for 2013-2014

Revised Wording to the National Advisory Committee on Immunization (NACI) Recommendation for Live Attenuated Influenza Vaccine (LAIV) in Healthy Children and Adolescents 2-17 Years of Age
2013
Influenza Statement on Seasonal Influenza Vaccine for 2012–2013 2012
Influenza Recommendations on the use of live, attenuated influenza vaccine (FluMist®): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012 2011
Influenza Recommendations on the use of MF59-Adjuvanted Trivalent Influenza Vaccine (Fluad®): Supplemental Statement of Seasonal Influenza Vaccine for 2011-2012 2011
Influenza Statement on Seasonal Influenza Vaccine for 2011–2012 2011
Influenza Addendum to the 2010-2011 Seasonal Trivalent Inactivated Influenza Vaccine 2011
Influenza Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011 2010
Influenza Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2009-2010 2009
Influenza Statement on Influenza Vaccination for the 2008-2009 Season 2008
Influenza Statement on Influenza Vaccination for the 2007-2008 Season 2007
Influenza Statement on Influenza Vaccination for the 2006-2007 Season 2006
Influenza Update on Influenza Vaccination for the 2005-2006 Season 2006
Influenza Statement on Influenza Vaccination for the 2003-2004 SeasonExternal link 2003
Influenza Supplementary Statement for the 2002-2003 Influenza Season: Update on Oculo-respiratory Syndrome in Association with Influenza VaccinationExternal link 2002
Influenza Statement on Influenza Vaccination for the 2002-2003 SeasonExternal link 2002
Influenza Supplementary Statement for the 2001-2002 Season: Influenza Vaccination of Persons Who Experienced Oculo-Respiratory Syndrome Following Previous Influenza Vaccination (ACS-7) External link 2001
Influenza Statement on Influenza Vaccination for the 2001-2002 Season (ACS-4) External link 2001
Influenza Supplementary statement on influenza vaccination: continued use of Fluviral® influenza vaccine in the 2000-2001 season (ACS-1)External link 2001
Influenza Statement on Influenza Vaccination for the 2000-2001 Season External link 2000
Measles Statement on Measles-Mumps-Rubella-Varicella VaccineExternal link 2010
Measles Measles Surveillance: Guidelines for Laboratory SupportExternal link 1998
Measles Interim Advisory on Measles Revaccination of Persons with Acquired Immunodeficiency Syndrome (AIDS)External link 1996
Measles Supplementary Statement on Measles Elimination in CanadaExternal link 1996
Measles Guidelines for Control of Measles Outbreaks in CanadaExternal link 1995
Meningococcal Disease Literature review on serogroup B invasive meningococcal disease: epidemiology, multicomponent meningococcal B vaccine characteristics and other factors for consideration (PDF document) 2014
Meningococcal Disease Advice for the use of the Multicomponent Meningococcal Serogroup B (4CMenB) Vaccine 2014
Meningococcal Disease

Update on the Use of Quadrivalent Conjugate Meningococcal Vaccines

2013
Meningococcal Disease

Update on the Invasive Meningococcal Disease and Meningococcal Vaccine Conjugate Recommendations

2009
Meningococcal Disease Meningococcal C Conjugate for Infants statement 2007
Meningococcal Disease Statement on Conjugate Meningococcal Vaccine for Serogroups A,C, Y and W135 2007
Meningococcal Disease Update on Meningococcal C Conjugate Vaccines 2005
Meningococcal Disease Supplementary Statement on Conjugate Meningococcal VaccinesExternal link 2003
Meningococcal Disease Statement on Recommended Use of Meningococcal Vaccines
External link
2001
MMR (Measles, Mumps, Rubella) Supplementary Statement on MMR Vaccine and Anaphylactic Hypersensitivity to Egg or Egg-Related AntigensExternal link 1996
MMRV (Measles, Mumps, Rubella, Varicella) Statement on Measles-Mumps-Rubella-Varicella Vaccine 2010
Mumps Statement on Measles-Mumps-Rubella-Varicella Vaccine 2010
Mumps Guidelines for the Prevention and Control of Mumps Outbreaks in Canada 2010
Mumps Statement on Mumps Vaccine 2007
Pertussis, Tetanus, and Diphtheria Update on Pertussis Vaccination in Pregnancy 2014
Pertussis, Tetanus, and Diphtheria Statement on the Booster for 4-6 year-olds for Protection against Pertussis 2014
Pertussis, Tetanus, and Diphtheria Statement on the recommended use of pentavalent and hexavalent vaccines 2007
Pertussis, Tetanus, and Diphtheria Literature review on DTaP based penta- and hexavalent vaccines approved for clinical use in Canada 2006
Pertussis, Tetanus, and Diphtheria Interval Between Administration of Vaccines Against Diphtheria, Tetanus, and Pertussis 2005
Pertussis, Tetanus, and Diphtheria Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, Haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age 2005
Pertussis, Tetanus, and Diphtheria Clarification - Prevention of Pertussis in Adolescents and Adults 2004
Pertussis, Tetanus, and Diphtheria Prevention of Pertussis in Adolescents and AdultsExternal link 2003
Pertussis, Tetanus, and Diphtheria Statement on Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria VaccineExternal link 2000
Pneumococcus Update on the Use of Pneumococcal Vaccines: Addition of Asthma as a High-Risk Condition 2014
Pneumococcus Statement on the Use of Conjugate Pneumococcal Vaccine - 13 Valent in Adults (Pneu-C-13) 2013
Pneumococcus Update on the Use of Conjugate Pneumococcal Vaccines in Childhood 2010
Pneumococcus Update on Pediatric Invasive Pneumococcal Disease and Recommended Use of Conjugate Pneumococcal Vaccines 2010
Pneumococcus Statement on the recommended use of pneumococcal 23-valent polysaccharide vaccine in homeless persons and injection drug users 2008
Pneumococcus Update On the Recommendations For The Routine Use of Pneumococcal Conjugate Vaccine For Infants 2006
Pneumococcus Recommendations for use of Pneumococcal 23-Valent Polysaccharide Vaccine During Shortage 2004
Pneumococcus Statement on the Recommended Use of Pneumococcal Conjugate Vaccine: AddendumExternal link 2003
Pneumococcus Statement On Recommended Use Of Pneumococcal Conjugate VaccineExternal link 2002
Poliomyelitis Statement on the recommended use of pentavalent and hexavalent vaccines 2007
Poliomyelitis Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B  Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age 2005
Rabies Vaccines Recommendations Regarding the Management of Bat Exposures to Prevent Human Rabies 2009
Rabies Vaccines Update on Rabies Vaccines 2005
Respiratory Syncytial Virus (RSV) Statement on the Recommended Use of Monoclonal Anti-RSV Antibody (Palivizumab)External link 2003
Rotavirus Literature Review on Rotavirus: Disease and Vaccine Characteristics 2010
Rotavirus Updated Statement on the use of Rotavirus Vaccines 2010
Rotavirus Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine 2008
Rubella Statement on Measles-Mumps-Rubella-Varicella Vaccine 2010
Smallpox Statement on Smallpox VaccinationExternal link 2002
Thimerosal in Vaccines Thimerosal: Updated Statement 2007
Thimerosal in Vaccines Updated Recommendations on the use of Thimerosal-Containing Vaccines in Canada 2005
Thimerosal in Vaccines Statement on ThimerosalExternal link 2003
Thimerosal in Vaccines Thimerosal in VaccinesExternal link 1999
Varicella Update on the Use of Herpes Zoster Vaccine 2014
Varicella Literature Review on One-Dose and Two-Dose Varicella Vaccination 2010
Varicella Statement on Measles-Mumps-Rubella-Varicella Vaccine 2010
Varicella Varicella Vaccination Two-Dose Recommendations. 2010
Varicella Updated Recommendations For The Use Of Varicella And MMR Vaccines In HIV-infected Individuals 2010
Varicella Statement on the Recommended Use of Herpes Zoster Vaccine 2010
Varicella Varizig™ as the varicella zoster immune globulin for the prevention of varicella In at-risk patients 2006
Varicella Update on Varicella 2004
Varicella NACI Update to Statement on Varicella VaccineExternal link 2002
Varicella Statement on Recommended Use of Varicella Virus VaccineExternal link 1999